ConductScience.org, home

Paper22010101

No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.

Dini G and 15 others. Blood, 2011. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission. Papers, record 22010101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22010101

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.
PubMed
Journal
Blood
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2026-05-18
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dini GGiorgio
2Zecca MMarco
3Balduzzi AAdriana
4Messina CChiara
5Masetti RRiccardo
6Fagioli FFranca
7Favre CClaudio
8Rabusin MMarco
9Porta FFulvio
10Biral EErika
11Ripaldi MMimmo
12Iori APAnna Paola
13Rognoni CCarla
14Prete AArcangelo
15Locatelli FFranco
16Associazione Italiana Ematologia ed Oncologia Pediatrica–Hematopoietic Stem Cell Transplantation (AIEOP-HSCT) GroupGroup

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
Precursor Cell Lymphoblastic Leukemia-LymphomaMajor topic
Adolescent
Chemoradiotherapy
Child
Child, Preschool
Cohort Studies
Female
Graft vs Host Disease
Humans
Infant
Infant, Newborn
Male
Multivariate Analysis
Outcome Assessment, Health Care
Proportional Hazards Models
Recurrence
Remission Induction
Survival Analysis
Survival Rate
Time Factors
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
41115238Immunotherapy in the up-front treatment of adult B-cell precursor acute lymphoblastic leukemia: when, how, who?Blood Adv2026https://conductscience.org/library/papers/41115238PubMed
39503988Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine.Paediatr Drugs2025https://conductscience.org/library/papers/39503988PubMed
37856089Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.Blood2023https://conductscience.org/library/papers/37856089PubMed
36875838The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation.Front Nutr2023https://conductscience.org/library/papers/36875838PubMed
36790458ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution.Ann Hematol2023https://conductscience.org/library/papers/36790458PubMed
35956160Antimicrobial Stewardship Interventions in Pediatric Oncology: A Systematic Review.J Clin Med2022https://conductscience.org/library/papers/35956160PubMed
35507103
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/35507103PubMed
35071133Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia.Front Pediatr2021https://conductscience.org/library/papers/35071133PubMed
34501237The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia.J Clin Med2021https://conductscience.org/library/papers/34501237PubMed
33557125Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review.J Pers Med2021https://conductscience.org/library/papers/33557125PubMed
33530464Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation.Int J Mol Sci2021https://conductscience.org/library/papers/33530464PubMed
32523362Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain.Clinicoecon Outcomes Res2020https://conductscience.org/library/papers/32523362PubMed
30302205Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant.Int J Hematol Oncol2016https://conductscience.org/library/papers/30302205PubMed
28686179When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia.J Clin Med2017https://conductscience.org/library/papers/28686179PubMed
28438676Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.Biol Blood Marrow Transplant2017https://conductscience.org/library/papers/28438676PubMed
26808568Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.Bone Marrow Transplant2016https://conductscience.org/library/papers/26808568PubMed
26266406Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children.Int J Mol Sci2015https://conductscience.org/library/papers/26266406PubMed
25961775Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?Bone Marrow Transplant2015https://conductscience.org/library/papers/25961775PubMed
25862561IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.Blood2015https://conductscience.org/library/papers/25862561PubMed
25387094Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.Bone Marrow Transplant2015https://conductscience.org/library/papers/25387094PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22010101

GET https://conductscience.org/api/papers/v1/22010101/cited_by?page=2